You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abiraterone

Showing 26 - 50 of 447
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

Not yet recruiting
  • Metastatic Cancer
  • Neoplasm, Prostate
  • Abiraterone acetate
  • +2 more
  • Bronx, New York
    James J. Peters VA Medical Center
Jun 16, 2022

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Prostate Cancer Trial in United States (Niraparib, Leuprolide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +3 more
Oct 18, 2022

Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Patient-specific adaptive therapy
  • +2 more
  • Camperdown, New South Wales, Australia
  • +6 more
Jan 11, 2023

Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

Enrolling by invitation
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Sep 18, 2022

Prostate Cancer Trial in Paris (Abiraterone acetate standard dose, Abiraterone acetate escalated dose)

Completed
  • Prostate Cancer
  • Abiraterone acetate standard dose
  • Abiraterone acetate escalated dose
  • Paris, France
    Department of Medical Oncology, Cochin Hospital
Jan 21, 2022

Abiraterone Acetate, Gene Polymorphism, Pharmacokinetic Trial in Wuhan (Abiraterone acetate tablets)

Active, not recruiting
  • Abiraterone Acetate
  • +4 more
  • Abiraterone acetate tablets
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 30, 2021

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

Withdrawn
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • +3 more
  • Los Angeles, California
  • +3 more
Jan 30, 2023

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate/Niraparib
  • +5 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 9, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial in Shanghai (Abiraterone Acetate Tablets (I), ZYTIGA®)

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

Castration-Resistant Prostate Cancer Trial in Las Vegas, Port Jefferson Station (Enzalutamide or Abiraterone or Apalutamid)

Recruiting
  • Castration-Resistant Prostate Cancer
  • Enzalutamide or Abiraterone or Apalutamid
  • Las Vegas, Nevada
  • +1 more
Apr 4, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (TQB3823 tablets, Abiraterone acetate tablets, prednisone acetate

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • TQB3823 tablets
  • +2 more
  • Chongqing, Chongqing, China
  • +4 more
Jun 1, 2022

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Prostate Cancer Metastatic Trial in Worldwide (ARV-110 in Combination with Abiraterone)

Recruiting
  • Prostate Cancer Metastatic
  • ARV-110 in Combination with Abiraterone
  • Santa Monica, California
  • +16 more
Jul 21, 2022

Prostate Cancer, Prostate Carcinoma, Metastatic Prostate Cancer Trial (Olaparib tablet, Abiraterone acetate, Prednisone tablet)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Olaparib tablet
  • +2 more
  • (no location specified)
Dec 7, 2021

Prostate Cancer Trial in United States (Cabazitaxel, Carboplatin, Abiraterone)

Recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +7 more
Apr 12, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United Kingdom, United States (PLX2853, Olaparib, Abiraterone acetate)

Terminated
  • Metastatic Castration-resistant Prostate Cancer
  • Chicago, Illinois
  • +7 more
Oct 4, 2022

Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer Trial in Worldwide (Abiraterone acetate, Prednisone)

Completed
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
Apr 20, 2022

Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +5 more
Jul 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Beijing, China
  • +35 more
Aug 9, 2022

Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated

Recruiting
  • Prostate Cancer
  • +2 more
  • Abiraterone
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 27, 2021

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy Trial in France (Abiraterone)

Completed
  • Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
  • Abiraterone
  • Bordeaux, France
  • +4 more
May 18, 2022